Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Brigo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
The Use of In Silico Models Within a Large Pharmaceutical CompanyAlessandro Brigo, Wolfgang Muster
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2022
Increasing the Value of Data Within a Large Pharmaceutical Company Through In Silico ModelsAlessandro Brigo, Doha Naga, Wolfgang Muster
Biophysical Journal|June 28, 2003
Protocol for MM/PBSA molecular dynamics simulations of proteinsFederico Fogolari, Alessandro Brigo, Henriette Molinari
Chemical Research in Toxicology|August 16, 2023
Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris HackathonDavide Bassani, Alessandro Brigo, Andrea Andrews-Morger
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitorsGabriela Iurcu Mustata, Alessandro Brigo, James M Briggs
Biophysical Journal|March 15, 2005
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domainAlessandro Brigo, Keun Woo Lee, Gabriela Iurcu Mustata, et al.
Chemical Research in Toxicology|May 4, 2011
Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitationsAlexander Hillebrecht, Wolfgang Muster, Alessandro Brigo, et al.
Proteins|April 9, 2005
Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitorAlessandro Brigo, Keun Woo Lee, Federico Fogolari, et al.
Chemical Research in Toxicology|December 21, 2019
Genotoxicity Assessment of Drug Metabolites in the Context of MIST and BeyondAndreas Zeller, Alessandro Brigo, Andreas Brink, et al.
Regulatory Toxicology and Pharmacology : RTP|September 2, 2023
Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessmentsAlex N Cayley, Robert S Foster, Alessandro Brigo, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
The Use of In Silico Models Within a Large Pharmaceutical CompanyAlessandro Brigo, Wolfgang Muster
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2022
Increasing the Value of Data Within a Large Pharmaceutical Company Through In Silico ModelsAlessandro Brigo, Doha Naga, Wolfgang Muster
Biophysical Journal|June 28, 2003
Protocol for MM/PBSA molecular dynamics simulations of proteinsFederico Fogolari, Alessandro Brigo, Henriette Molinari
Chemical Research in Toxicology|August 16, 2023
Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris HackathonDavide Bassani, Alessandro Brigo, Andrea Andrews-Morger
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitorsGabriela Iurcu Mustata, Alessandro Brigo, James M Briggs
Biophysical Journal|March 15, 2005
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domainAlessandro Brigo, Keun Woo Lee, Gabriela Iurcu Mustata, et al.
Chemical Research in Toxicology|May 4, 2011
Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitationsAlexander Hillebrecht, Wolfgang Muster, Alessandro Brigo, et al.
Proteins|April 9, 2005
Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitorAlessandro Brigo, Keun Woo Lee, Federico Fogolari, et al.
Chemical Research in Toxicology|December 21, 2019
Genotoxicity Assessment of Drug Metabolites in the Context of MIST and BeyondAndreas Zeller, Alessandro Brigo, Andreas Brink, et al.
Regulatory Toxicology and Pharmacology : RTP|September 2, 2023
Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessmentsAlex N Cayley, Robert S Foster, Alessandro Brigo, et al.
Pageof 3